MAMMATYPER
LIVE

Serial Number

79363341

Owner

Shuwen Biotech Co., Ltd.

Attorney

Michael T. Smith

Filing Date

Nov 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MAMMATYPER Trademark

Serial Number: 79363341 • Registration: 7404160

MAMMATYPER is a trademark filed by Shuwen Biotech Co., Ltd. on November 7, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Shuwen Biotech Co., Ltd. (6 trademarks)

1st Floor, Building 8, 333 Changhong Zhongjie,

Entity Type: 03

Trademark Details

Filing Date

November 7, 2022

Registration Date

June 4, 2024

Published for Opposition

March 19, 2024

Goods & Services

Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancer

Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipment, namely, equipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening services

Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposes, namely, X-ray diagnostic apparatus

Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncology, namely, breast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancer

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 28, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 7, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 16, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 16, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 4, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 4, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 4, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 19, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 28, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 12, 2024 TROA
ATTORNEY REVIEW COMPLETED
Oct 31, 2023 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Oct 30, 2023 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 16, 2023 CRCV
REFUSAL PROCESSED BY IB
Aug 1, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 13, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 13, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 6, 2023 RFCR
NON-FINAL ACTION WRITTEN
Jun 5, 2023 CNRT
ASSIGNED TO EXAMINER
May 27, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Mar 25, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Mar 4, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 28, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 27, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 23, 2023 REPR